Y-Biologics, Inc. (KOSDAQ:338840)
South Korea · Delayed Price · Currency is KRW 18,210
-1,030 (-5.35%)
At close: May 20, 2026
Y-Biologics Market Cap
Y-Biologics has a market cap or net worth of 276.39 billion as of May 21, 2026. Its market cap has increased by 142.19% in one year.
Market Cap
276.39B
Enterprise Value
246.88B
Revenue
2.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
18,210.00
Market Cap Chart
Since December 5, 2023, Y-Biologics's market cap has increased from 177.50B to 276.39B, an increase of 55.72%. That is a compound annual growth rate of 19.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 276.39B | -20.48% |
| Dec 30, 2025 | 347.58B | 205.76% |
| Dec 30, 2024 | 113.68B | -50.64% |
| Dec 28, 2023 | 230.30B | 29.75% |
| Dec 5, 2023 | 177.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intops | 295.30B |
| CJ Freshway | 294.42B |
| EMRO., Incorporated. | 294.23B |
| Contec.,Co.Ltd | 294.17B |
| Kangstem Biotech | 292.04B |
| Ycchem | 291.79B |
| NOVAREX | 291.58B |
| ASICLAND | 290.62B |